KeyBanc analyst Matthew Gillmor upgraded Alignment Healthcare (ALHC) to Overweight from Sector Weight with a $21 price target The firm says the company is emerging as a better Medicare Advantage value-based care “mousetrap” relative to traditional models. The company’s s platform is driving consistent improvement in hospital utilization and its savings are reinvested back into member benefits, the analyst tells investors in a research note. KeyBanc believes Alignment’s model will support market share gains and above-average growth.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ALHC:
- Alignment Healthcare: Strong Performance and Promising Outlook Justify Buy Rating
- Alignment Healthcare’s Earnings Call Highlights Growth and Challenges
- Barclays upgrades Alignment to Equal Weight on reduced risk
- Alignment Healthcare upgraded to Equal Weight from Underweight at Barclays
- Alignment Healthcare Reports Strong Q2 2025 Results